These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 3687806)

  • 1. Vasodilators, antihypertensive therapy and the kidney.
    Hollenberg NK
    Am J Cardiol; 1987 Dec; 60(17):57I-60I. PubMed ID: 3687806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kidney and effective antihypertensive therapy.
    Hollenberg NK
    Am J Cardiol; 1985 Dec; 56(16):52H-55H. PubMed ID: 2866706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies in antihypertensive therapy: implications of the kidney.
    Hollenberg NK
    Am J Med; 1986 Dec; 81(6A):15-9. PubMed ID: 2879443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kidney and strategies for the treatment of hypertension.
    Hollenberg NK
    Am J Med; 1984 Oct; 77(4A):60-3. PubMed ID: 6207726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of antihypertensive therapy on renal function.
    Rappelli A; Baldinelli A; Zingaretti O; Espinosa E; Salvi S; Fulgheri PD
    J Hypertens Suppl; 1991 Dec; 9(3):S37-40. PubMed ID: 1686783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilators, antihypertensive therapy, and the kidney.
    Hollenberg NK
    Circulation; 1987 Jun; 75(6 Pt 2):V39-42. PubMed ID: 2882875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1-induced vasopressor responses in essential hypertension.
    Kaasjager KA; Koomans HA; Rabelink TJ
    Hypertension; 1997 Jul; 30(1 Pt 1):15-21. PubMed ID: 9231815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive therapy and renal function.
    Mimran A
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S19-25. PubMed ID: 8872296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension.
    Katzman PL; Henningsen NC; Fagher B; Thulin T; Hulthén UL
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):360-4. PubMed ID: 1691357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kidney and antihypertensive therapy.
    Hollenberg NK
    Am J Cardiol; 1987 Jan; 59(2):76A-79A. PubMed ID: 2880492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE; Wilson DM; Burnett JC; Johnson CM; Offord KP
    Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of calcium antagonists and converting enzyme inhibitors on renal function under normal and hypertensive conditions.
    Romero JC; Ruilope LM; Bentley MD; Fiksen-Olsen MJ; Lahera V; Vidal MJ
    Am J Cardiol; 1988 Oct; 62(11):59G-68G. PubMed ID: 3051997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoconstriction during acute hypervolemic hemodilution in hypertensive patients is not prevented by calcium blockade.
    Wysocki M; Andersson OK; Persson B; Bagge U
    Angiology; 1998 Jan; 49(1):41-8. PubMed ID: 9456163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of converting enzyme inhibition on the enhanced proximal sodium reabsorption induced by chronic diuretic treatment in patients with essential hypertension.
    van Schaik BA; Geyskes GG; Dorhout Mees EJ
    Nephron; 1987; 47(3):167-72. PubMed ID: 2825050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model.
    Hallow KM; Lo A; Beh J; Rodrigo M; Ermakov S; Friedman S; de Leon H; Sarkar A; Xiong Y; Sarangapani R; Schmidt H; Webb R; Kondic AG
    Am J Physiol Regul Integr Comp Physiol; 2014 May; 306(9):R647-62. PubMed ID: 24500431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.